Mode
Text Size
Log in / Sign up

Digital journaling shows modest anxiety reduction in young adults with mild-to-moderate symptoms

Digital journaling shows modest anxiety reduction in young adults with mild-to-moderate symptoms
Photo by Nik / Unsplash
Key Takeaway
Consider digital journaling for scalable phenotyping with modest, uncertain anxiety benefit in young adults.

This randomized controlled trial evaluated a digital journaling intervention on a mobile platform in 507 young adults with mild-to-moderate anxiety and depression symptoms. The primary outcome was anxiety reduction at an 8-week endpoint with a 1-month follow-up. The intervention was compared to a control condition.

The main finding was a modest reduction in anxiety relative to controls, with effect sizes ranging from d = 0.16 to 0.19. However, these effects were small and did not remain statistically significant after correction for multiple comparisons. Complementary Bayesian analyses provided moderate-to-strong directional evidence (90-97%) supporting a modest anxiety reduction. Secondary analyses for behavioral phenotyping found high-risk journal entries were more common among younger users (OR = 0.77 per year of age, p = 0.007), risk probability was highest during late-night and overnight hours, and affective volatility was associated with acute declines within the same affective dimension but not with escalation to high-risk states.

Safety and tolerability data were not reported. A key limitation is that the primary anxiety reduction effects did not survive correction for multiple comparisons. The study suggests privacy-preserving digital journaling can support scalable longitudinal behavioral phenotyping and real-time risk monitoring while providing only modest clinical benefit for anxiety symptoms.

Study Details

Study typeRct
Sample sizen = 507
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
Digital mental health applications enable high-frequency behavioral monitoring and scalable interventions. Journaling provides a therapeutically grounded and intrinsically engaging activity for many users. AI-based text analysis enables privacy-preserving phenotyping of clinically relevant patterns in naturalistic writing, including emotional distress and behavioral risk (e.g., indicators of intent, planning, or preparatory actions for harm to self or others). We evaluated a mobile journaling platform in an 8-week randomized controlled trial (N = 507) of young adults with mild-to-moderate anxiety and depression symptoms. Journaling produced modest reductions in anxiety relative to controls at the 8-week endpoint and 1-month follow-up (d = 0.16-0.19). Effects were small and did not remain significant after correction for multiple comparisons; complementary Bayesian models nonetheless provided moderate-to-strong directional evidence (90-97%) supporting a modest anxiety reduction. In parallel, behavioral phenotyping analyses showed that high-risk journal entries were more common among younger users (OR = 0.77 per year of age, p = 0.007). Text-based risk signals and self-reported energy exhibited significant circadian variation (e.g., risk probability was highest during late-night and overnight hours). Within-person analyses demonstrated strong short-term persistence in mood and risk states, with calm/relaxed showing the highest persistence and anxious/agitated exhibiting the lowest persistence. High-risk journal entries clustered temporally and were preceded by sustained low valence and energy. Although affective volatility was associated with acute declines within the same affective dimension (pleasantness or energy), it was not associated with escalation to high-risk states. Key behavioral dynamics observed in the trial were replicated in an independent general population dataset (N = 16,630). Collectively, these findings demonstrate that privacy-preserving digital journaling can support scalable longitudinal behavioral phenotyping and real-time risk monitoring while providing modest clinical benefit for anxiety symptoms.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.